Author Question: Technician A says that indexing the distributor is the same as setting ignition timing. Technician B ... (Read 205 times)

JGIBBSON

  • Hero Member
  • *****
  • Posts: 538
Technician A says that indexing the distributor is the same as setting ignition timing. Technician B says that a distributor that is not phased correctly can cause a misfire and rough idle. Which technician is correct?
 
  A) Technician A only B) Technician B only
  C) Both technicians D) Neither technician

Question 2

A DTC P0301 (misfire on cylinder 1 ) on a waste-spark system could be caused by any of these EXCEPT ________.
 
  A) Open plug wire on cylinder 1
  B) Open spark plug wire on cylinder 4 (companion to cylinder 1)
  C) Defective pick-up coil
  D) Defective plug connector



pocatato

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

B

Answer to Question 2

C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

Elderly adults are at greatest risk of stroke and myocardial infarction and have the most to gain from prophylaxis. Patients ages 60 to 80 years with blood pressures above 160/90 mm Hg should benefit from antihypertensive treatment.

Did you know?

The newest statin drug, rosuvastatin, has been called a superstatin because it appears to reduce LDL cholesterol to a greater degree than the other approved statin drugs.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library